GLP-1 receptor agonists such as semaglutide (marketed as Ozempic and Wegovy) and dual GIP/GLP-1 agonist tirzepatide (Mounjaro) have become increasingly popular for weight loss in both women and men
Given the mucosal and wound-healing evidence PDA could be particularly beneficial in surgeries where mucosal, vascular, or tendon healing is critical (e.g., bowel resections, ligament repairs)
BMC Neurosci
However, things may be changing in the research world
Not that this has not been demonstrated before but to my surprise the questions on thyroid tumors and GLP-1 RA keep coming especially from non-endocrinologists This was a huge study that included a total of 460,032 users of GLP-1RAs, 717,792 users of SGLT2is, 2,055,583 users of DPP-4is, and 1,119,868 users of SUs GLP-1RA exposure was not associated with an increased risk of thyroid tumors compared with SGLT2is, DPP-4is, or SUs (meta-analysis: GLP-1RA vs
Weak grip strength can interfere with a persons ability to perform daily activities